ARWRVSAXTI• 3 Months (Normalized)
ARWR vs AXTI (Arrowhead Pharmaceuticals Inc. vs AXT Inc)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARWR Performance $82.85
+7.39%
Arrowhead Pharmaceuticals Inc.
Normalized Baseline0.00%
AXTI Performance $64.77
-41.51%
AXT Inc
Normalized Baseline0.00%
Alpha Spread Margin ARWR LEADS
+48.9%
ARWR outperforming by 48.90%
ARWRAXTI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARWR AXTI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ARWR Price | ARWR Gain (%) | AXTI Price | AXTI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $82.85 | +7.39% | $64.77 | -41.51% | +48.90% |
| Sep 10, 2026 | $82.76 | +7.27% | $64.70 | -41.57% | +48.84% |
| Sep 09, 2026 | $82.63 | +7.10% | $68.91 | -37.77% | +44.87% |
| Sep 08, 2026 | $85.11 | +10.32% | $69.56 | -37.19% | +47.51% |
| Sep 04, 2026 | $86.34 | +11.91% | $61.64 | -44.34% | +56.25% |
| Sep 03, 2026 | $86.49 | +12.11% | $56.20 | -49.25% | +61.36% |
| Sep 02, 2026 | $85.37 | +10.65% | $56.95 | -48.57% | +59.22% |
| Sep 01, 2026 | $82.74 | +7.25% | $56.11 | -49.33% | +56.58% |
| Aug 31, 2026 | $82.39 | +6.79% | $60.61 | -45.27% | +52.06% |
| Aug 28, 2026 | $84.91 | +10.06% | $58.63 | -47.06% | +57.12% |
| Aug 27, 2026 | $88.59 | +14.83% | $66.92 | -39.57% | +54.40% |
| Aug 26, 2026 | $89.12 | +15.52% | $65.18 | -41.14% | +56.66% |
| Aug 25, 2026 | $88.88 | +15.20% | $67.45 | -39.09% | +54.29% |
| Aug 24, 2026 | $86.73 | +12.42% | $65.40 | -40.94% | +53.36% |
| Aug 21, 2026 | $87.11 | +12.91% | $70.74 | -36.12% | +49.03% |
Page 1 of 5